09.21.07
DSM Pharmaceutical Products has made several management appointments. Mr. Leendert Staal, currently business group director DSM Pharmaceutical Products, will be appointed president of DSM Nutritional Products, reporting to Stephan Tanda, member of the managing board of DSM. Mr. Bob Hartmayer will succeed Mr. Staal as business group director, president and chief executive officer of DSM Pharmaceutical Products, reporting to Jan Zuidam, also a member of the managing board. Mr. Hartmayer is currently business group director DSM Elastomers.
Also, the following management appointments will take effect on October 1, 2007: Mr. Luca Mantovani, vice president citric acid, DSM Nutritional Products, will be appointed business unit director, president DSM Pharma Chemicals; Mr. Terry Novak, chief marketing officer DSM Pharmaceuticals & Biologics, will be appointed business unit director, president DSM Pharmaceuticals, Inc.; Ms. Karen King, senior vice president strategic business development, will be appointed business unit director, president DSM Biologics; Mr. Hans Engels, chief operating officer DSM Pharmaceuticals & Biologics will be appointed chief operating officer, DSM Pharmaceutical Products Business Group. Mr. Mantovani, Mr. Novak, Ms. King, and Mr. Engels, will report to Mr. Hartmayer.
Also, Mr. Stephen Lijoi, vice president of operations in Greenville, will be appointed vice president and site director for DSM Pharmaceuticals Greenville, NC site reporting to Mr. Novak.
Also, the following management appointments will take effect on October 1, 2007: Mr. Luca Mantovani, vice president citric acid, DSM Nutritional Products, will be appointed business unit director, president DSM Pharma Chemicals; Mr. Terry Novak, chief marketing officer DSM Pharmaceuticals & Biologics, will be appointed business unit director, president DSM Pharmaceuticals, Inc.; Ms. Karen King, senior vice president strategic business development, will be appointed business unit director, president DSM Biologics; Mr. Hans Engels, chief operating officer DSM Pharmaceuticals & Biologics will be appointed chief operating officer, DSM Pharmaceutical Products Business Group. Mr. Mantovani, Mr. Novak, Ms. King, and Mr. Engels, will report to Mr. Hartmayer.
Also, Mr. Stephen Lijoi, vice president of operations in Greenville, will be appointed vice president and site director for DSM Pharmaceuticals Greenville, NC site reporting to Mr. Novak.